Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.1900
0.00 (0.00%)
Sep 4, 2026, 4:00 PM EST
Bio Essence Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0 | - | 0 | - | 0.01 | 0 |
Cash & Short-Term Investments | 0 | - | 0 | - | 0.01 | 0 |
Cash Growth | - | - | - | - | 1966.67% | -94.31% |
Accounts Receivable | - | 0.02 | 0.01 | - | 0.01 | 0.02 |
Other Receivables | 0 | - | - | - | - | - |
Receivables | 0.47 | 0.41 | 0.01 | - | 0.01 | 0.02 |
Inventory | - | - | - | - | 0.18 | 0.21 |
Prepaid Expenses | 0.12 | 0 | 0.2 | - | 0.01 | 0.03 |
Other Current Assets | 0.01 | 0.01 | 0.07 | 0.3 | 0 | - |
Total Current Assets | 0.61 | 0.42 | 0.28 | 0.3 | 0.2 | 0.26 |
Property, Plant & Equipment | - | - | - | 1.43 | 1.3 | 1.39 |
Other Intangible Assets | 3.4 | 0 | 0 | 0 | 0 | 0 |
Other Long-Term Assets | - | - | - | 1.03 | 0.04 | 0.04 |
Total Assets | 4 | 0.42 | 0.28 | 2.76 | 1.55 | 1.7 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 0.05 | 0.02 | 0.01 | 0.05 | 0.06 |
Accrued Expenses | 0.01 | 0.04 | 0 | 0 | 0.03 | 0.1 |
Short-Term Debt | - | 0 | 1.19 | 1.8 | 3.21 | 2.41 |
Current Portion of Long-Term Debt | 0 | 0 | 0 | 0 | 0.02 | 0.02 |
Current Portion of Leases | 1.51 | 1.5 | 1.07 | 0.5 | 0.17 | 0.16 |
Other Current Liabilities | 0.07 | 0.85 | 0.52 | 0.14 | 0.08 | - |
Total Current Liabilities | 1.61 | 2.44 | 2.8 | 2.45 | 3.56 | 2.76 |
Long-Term Debt | 0.06 | 0.06 | 0.06 | 0.05 | 0.24 | 0.25 |
Long-Term Leases | - | - | 0.39 | 0.94 | 0.99 | 1.12 |
Other Long-Term Liabilities | - | - | - | 0.98 | - | - |
Total Liabilities | 1.66 | 2.5 | 3.25 | 4.42 | 4.79 | 4.13 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 11.41 | 7.48 | 7.48 | 7.48 | 4.93 | 4.93 |
Retained Earnings | -9.08 | -9.55 | -10.45 | -9.14 | -8.17 | -7.36 |
Shareholders' Equity | 2.34 | -2.07 | -2.97 | -1.66 | -3.24 | -2.43 |
Total Liabilities & Equity | 4 | 0.42 | 0.28 | 2.76 | 1.55 | 1.7 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1.57 | 1.56 | 2.71 | 3.29 | 4.62 | 3.96 |
Net Cash (Debt) | -1.57 | -1.56 | -2.71 | -3.29 | -4.61 | -3.96 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.04 | -0.04 | -0.07 | -0.10 | -0.14 | -0.12 |
Filing Date Shares Outstanding | 53.81 | 38.01 | 38.01 | 38.01 | 33.01 | 33.01 |
Total Common Shares Outstanding | 53.81 | 38.01 | 38.01 | 38.01 | 33.01 | 33.01 |
Working Capital | -1 | -2.02 | -2.52 | -2.15 | -3.35 | -2.49 |
Book Value Per Share | 0.04 | -0.05 | -0.08 | -0.04 | -0.10 | -0.07 |
Tangible Book Value | -1.05 | -2.07 | -2.97 | -1.66 | -3.24 | -2.43 |
Tangible Book Value Per Share | -0.02 | -0.05 | -0.08 | -0.04 | -0.10 | -0.07 |
Machinery | - | - | - | 0.06 | 0.41 | 0.29 |
Leasehold Improvements | - | - | - | 0 | 0.06 | 0.06 |